Carlos L. Arteaga, MD, Named Director of UT Southwestern Cancer Center


Get Permission

Carlos L. Arteaga, MD

Carlos L. Arteaga, MD

CARLOS L. ARTEAGA, MD, has been named Director of the Harold C. Simmons Comprehensive Cancer Center and Associate Dean of Oncology Programs at The UT Southwestern Medical Center in Dallas. 

Roles and Research at Vanderbilt 

DR. ARTEAGA IS CURRENTLY Director of the Center for Cancer Targeted Therapies (C2T2), Director of the Breast Cancer Research Program, Associate Director for Clinical Research, Donna S. Hall Chair in Breast Cancer, and Professor of Medicine and Cancer Biology at Vanderbilt-Ingram Cancer Center (VICC). 

Since 2001, he has been the leader of the Vanderbilt Specialized Program of Research Excellence (SPORE) in Breast Cancer, a program that is in its third 5-year round of funding from the National Cancer Institute (NCI). 

As the founding Director of C2T2, he helped launch a center that integrates an early-phase clinical trials program with a personalized cancer medicine infrastructure with expertise in tumor tissue-based molecular methods, as well as a core resource with novel functional imaging methods. 

Dr. Arteaga is internationally recognized for his research in oncogene signaling and molecular therapeutics in breast cancer, with an emphasis on targeted therapies, mechanisms of drug resistance, and investigator-initiated clinical trials. Early in his career, he was the first to identify the roles of insulin-like growth factor (IGF-I) receptors and transforming growth factor-beta (TGF-beta) in breast cancer progression and their use as therapeutic targets. 

More recently, Dr. Arteaga and his team have focused on presurgical and neoadjuvant therapies to discover molecular biomarkers that are useful for patient selection into clinical trials and the role of oncogenes and tumor suppressors in resistance to antiestrogens and anti-HER2 therapies in breast cancer. 

Leadership in Multiple Societies 

DR. ARTEAGA SERVED as President of the American Association for Cancer Research (AACR) from 2014 to 2015. He has served on the NCI Board of Scientific Counselors, as a member of the AACR Board of Directors, and as Co- Chair of the Annual San Antonio Breast Cancer Symposium. 

Dr. Arteaga is an elected fellow of the American Association for the Advancement of Science, a fellow of the AACR Academy, an elected member of the American Society for Clinical Investigation and the Association of American Physicians, and a member of the Susan G. Komen Scientific Advisory Board. He also serves on the advisory boards of several academic breast cancer programs and NCI-designated cancer centers. 

During his career, Dr. Arteaga has received several awards, including the AACR Richard and Hinda Rosenthal Award, the American Cancer Society Clinical Research Professor Award, the Gianni Bonadonna Award from ASCO, the Brinker Award for Scientific Distinction from the Susan G. Komen Foundation, the 2015 Prize for Scientific Excellence in Medicine from the American-Italian Cancer Foundation, and the Clinical Investigator Award from the U.S. Department of Veterans Affairs. ■



Advertisement

Advertisement



Advertisement